The role of intracranial hypertension in the pathogenesis of central serous chorioretinopathy

Author(s):  
A.N. Zlobina ◽  
◽  
S.I. Zhukova ◽  
T.N. Iureva ◽  
A.A. Zaika ◽  
...  

Central serous chorioretinopathy (CSCR) is a pachychoroid condition, but the causes of pachychoroid development remain unknown. Taking into account the anatomical features of the blood supply to the eyeball, it was suggested that the phenomena of pachychoroid can be caused by intracranial hypertension. Purpose. Evaluate blood supply disorders at the level of eyeball vessels, intracranial vessels and vertebrobasilar basin in patients with CSCR. Material and methods. 10 patients with CSCR were examined, 4 of them additionally underwent magnetic resonance imaging (МРТ) of the brain and cervical spine, intra-and extracranial arterio-and venography, and ultrasound of extra-and intracranial vessels. Results. By OCT data, all patients had significant increase in the choroidal thickness both in eyes with CSCR, and in fellow eyes. OCT of the optic disc revealed subarachnoid space expansion - a marker of intracranial hypertension. By ultrasound B-scan data, 8 patients with CSCR showed moderate expansion of the perineural space of the optic nerve and significant expansion of orbital vessels, which also indicates intracranial hypertension. By MRI data, all patients showed signs of internal hydrocephalus, which may indicate intracranial hypertension. In addition, the presence of signs of cervical osteochondrosis and asymmetry in the vertebral arteries was established. In 50% of cases, there was a decrease in intravascular blood flow along the orbital vein on the side of the affected eye, and an asymmetry of venous blood flow along the transverse and cavernous sinuses. By ultrasound dopplerography signs of intracranial venous hypertension of extra-and intracranial vessels were revealed. Conclusion. The role of pathological changes of central genesis in the development of CSСR has been established, requiring interdisciplinary research and expansion of therapeutic measures aimed at limiting the identified disorders. Key words: central serous chorioretinopathy, pachychoroid condition, intracranial hypertension.

1986 ◽  
Vol 251 (5) ◽  
pp. G674-G677 ◽  
Author(s):  
J. N. Benoit ◽  
B. Zimmerman ◽  
A. J. Premen ◽  
V. L. Go ◽  
D. N. Granger

The role of glucagon as a blood-borne mediator of the hyperdynamic circulation associated with chronic portal venous hypertension was assessed in the rat portal vein stenosis model. Selective removal of pancreatic glucagon from the circulation was achieved by intravenous infusion of a highly specific glucagon antiserum. Blood flow to splanchnic organs, kidneys, and testicles was measured with radioactive microspheres, and the reference-sample method. Glucagon antiserum had no effect on blood flow in the gastrointestinal tract of sham-operated (control) rats. However, the antiserum produced a significant reduction in hepatic arterial blood flow in the control rats, suggesting that glucagon contributes significantly to the basal tone of hepatic arterioles. In portal hypertensive rats glucagon antiserum significantly reduced blood flow to the stomach (22%), duodenum (25%), jejunum (24%), ileum (26%), cecum (27%), and colon (26%). Portal venous blood flow was reduced by approximately 30%. The results of this study support the hypothesis that glucagon mediates a portion of the splanchnic hyperemia associated with chronic portal hypertension.


JAMA ◽  
1966 ◽  
Vol 198 (7) ◽  
pp. 784-785 ◽  
Author(s):  
A. Neistadt

Life ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 508
Author(s):  
Robert K. Townsend ◽  
Kyle M. Fargen

Idiopathic intracranial hypertension (IIH) is a debilitating condition that has traditionally been difficult to treat. In recent years, there has been increasing focus on the role of intracranial venous hypertension in the pathophysiology of IIH. Based on increased understanding of this pathophysiology, venous sinus stenting (VSS) has emerged as a safe and reliable treatment for a certain population of patients with IIH. Stratifying patients with IIH based on the status of their venous outflow can provide insight into which patients may enjoy reduction in their symptoms after VSS and provides information regarding why some patients may have symptom recurrence. The traditional view of IIH as a disease due to obesity in young women has been cast into doubt as the understanding of the role of intracranial venous hypertension has improved.


2009 ◽  
Vol 8 (2,3) ◽  
pp. 125-132 ◽  
Author(s):  
Erik Levin ◽  
Deborah Macintosh ◽  
Tanya Baker ◽  
Mark Weatherall ◽  
Richard Beasley

2000 ◽  
Vol 28 (9) ◽  
pp. 3181-3184 ◽  
Author(s):  
Yasuhiro Umemoto ◽  
Shinichi Nishi ◽  
Mituo Shindoh ◽  
Akira Asada

Sign in / Sign up

Export Citation Format

Share Document